Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.78x is 138% below its 5-year average of 2.07x, around the middle of its 5-year range (-8.97x–3.93x).
1817.17% below its 12-month average of 0.05x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-07-03): 3.93x.
INTEREST COVERAGE RATIO
-0.78x
INTEREST COVERAGE RATIO AVG TTM
0.05x
INTEREST COVERAGE RATIO AVG 3Y
1.87x
INTEREST COVERAGE RATIO AVG 5Y
2.07x
INTEREST COVERAGE RATIO AVG 10Y
1.96x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1817.17%
CURRENT VS 3Y AVG
-141.76%
CURRENT VS 5Y AVG
-137.72%
CURRENT VS 10Y AVG
-139.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+87.76%
vs the sector median at left
Varex Imaging Corporation
Market Cap
$778.01M
Interest Coverage Ratio
-0.78x
TTM Avg
0.05x
3Y Avg
1.87x
5Y Avg
2.07x
Market Cap
$777.34M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$776.24M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$785.03M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$789.34M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$765.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$761.37M
Interest Coverage Ratio
1.73x
TTM Avg
1.55x
3Y Avg
1.27x
5Y Avg
1.31x
Market Cap
$753.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Varex Imaging Corporation (VREX) | $778.01M | -0.78x | 0.05x | 1.87x | 2.07x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -5.87x | 6.84x | 6.84x | 3.53x |
| Geron Corporation (GERN)vs › | $776.24M | -1.65x | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | 1.76x | 1.92x | 1.86x | 1.93x |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | N/A | 85.72x | 85.72x | 85.72x |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 1.73x | 1.55x | 1.27x | 1.31x |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $804.16M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | N/A | N/A | N/A | N/A |
Interest Coverage
-0.8x
Debt/Equity
0.75
Current Ratio
3.38
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-03 | 3.93x |
| 2026-04-03 | 0.83x |
| 2026-01-02 | 1.95x |
| 2025-10-03 | 2.48x |
| 2025-07-04 | -8.97x |
| 2025-04-04 | 2.13x |
| 2025-01-03 | 1.37x |
| 2024-09-27 | 1.40x |
| 2024-06-28 | 1.22x |
| 2024-03-29 | 0.95x |
| 2023-12-29 | 0.91x |
| 2023-09-30 | 3.38x |
| 2023-06-30 | 3.61x |
| 2023-03-31 | 2.14x |
| 2022-12-30 | 1.73x |
| 2022-09-30 | 2.62x |
| 2022-07-01 | 2.45x |
| 2022-04-01 | 2.33x |
| 2021-12-31 | 1.41x |
| 2021-09-30 | 2.45x |
| 2021-07-02 | 2.42x |
| 2021-04-02 | 1.52x |
| 2021-01-01 | 0.59x |
| 2020-09-30 | -0.89x |
| 2020-07-03 | -3.88x |
| 2020-04-03 | 0.30x |
| 2020-01-03 | 0.85x |
| 2019-09-30 | 3.00x |
| 2019-06-28 | 0.90x |
| 2019-03-29 | 2.64x |
| 2018-12-28 | 2.04x |
| 2018-09-30 | 1.23x |
| 2018-06-29 | 1.35x |
| 2018-03-30 | 3.07x |
| 2017-12-29 | 2.47x |
| 2017-09-30 | 4.11x |
| 2017-06-30 | 3.69x |
| 2017-03-31 | 23.50x |
| 2016-12-30 | 31.00x |
| 2016-09-30 | 47.14x |
| 2016-06-30 | 71.00x |
| 2016-03-31 | 50.40x |
| 2015-12-31 | 75.33x |
| 2015-09-30 | 65.00x |